Developmental
Genomics

Signs of Developmental Delay and When Genetic Testing May Help

Developmental delays are often first noticed in structured settings like school or daycare, where children are compared with peers of the same age. When a child consistently struggles with learning, communication, or social interaction, clinicians and families may begin searching for answers. In some cases, these symptoms may indicate conditions such as global developmental delay and intellectual disability, which may have underlying genetic causes.

Blog
Education

Key Takeaways

  • Developmental delays may first become noticeable when children enter school or structured learning environments.
  • Some developmental delays have an underlying genetic cause.
  • Professional guidelines now recommend genomic sequencing as a first-line test for certain neurodevelopmental conditions.
  • Earlier diagnosis may help families access appropriate medical care and educational support.

When Developmental Differences Become More Noticeable

For many families, developmental concerns first arise when children begin school.

Teachers may notice that a child has difficulty learning new concepts, recalling recently taught material, or interacting with peers. In a classroom environment, where developmental milestones are easier to compare across age groups, these differences may become clearer.

These early observations often lead to referrals for further evaluation.

Signs of Developmental Delay

Developmental delays can appear in several areas of childhood development, including:

  • language and communication
  • motor coordination
  • learning and memory
  • social interaction
  • behavior and attention

In some cases, these symptoms may indicate conditions such as global developmental delay, intellectual disability, or autism spectrum disorder.

Because many of these conditions can have genetic causes, clinicians may consider genomic testing as part of the diagnostic process.

Why Genetic Testing Is Increasingly Recommended

Recent guidance from the American Academy of Pediatrics recommends exome or genome sequencing as first-line tests for children with global developmental delay or intellectual disability when the cause is not already known.

Genomic testing allows clinicians to evaluate thousands of genes simultaneously, helping identify genetic variants that may explain a child’s symptoms.

Providers can learn more about whole exome sequencing and whole genome sequencing as diagnostic tools.

Reducing the Diagnostic Odyssey

Without comprehensive testing, many children with rare diseases experience long diagnostic journeys.

Research suggests patients with rare diseases may experience:

  • an average of five years waiting for diagnosis
  • multiple specialist visits and tests
  • delayed access to appropriate treatments or support services

This prolonged search for answers is often referred to as the diagnostic odyssey.

Earlier genomic testing may help shorten this process and provide clinicians with clearer diagnostic insights.

Earlier Diagnosis Can Help Support Learning and Development

When a genetic diagnosis explains a child’s developmental challenges, it may help guide both medical care and educational planning.

For example, a confirmed diagnosis may support access to:

  • specialized therapies
  • individualized education programs (IEPs)
  • targeted behavioral or developmental interventions

Aligning clinical care and educational support with a child’s diagnosis can help improve outcomes and provide families with clearer next steps.

Learn More About Genomic Testing for Developmental Conditions

Genomic testing can help clinicians identify genetic causes of developmental delay and guide more informed care decisions.

Related articles

Developmental
Epilepsy
Exome
Rare Disease Diagnostics
Mora’s story: How an early SYNGAP1 diagnosis changed her care

When Mora began missing developmental milestones, her parents trusted their instincts and continued searching for answers. Exome sequencing identified SYNGAP1-related disorder, helping her family and care team proactively monitor for seizures and access earlier interventions and specialized care.

Exome
Genomics
Technology
GeneDx Launches Easy Order for ExomeDx™ with CMA in the Provider Portal

GeneDx has launched Easy Order, a guided Provider Portal experience designed to help providers submit eligible ExomeDx™ orders with CMA more efficiently, with fewer manual steps and more complete information from the start.

Payor
Education
Genomics
Financial
Strengthening Health Plan Collaboration to Improve Claims Accuracy and Patient Access

GeneDx’s Clinical Billing Integrity team works across clinical, coding, credentialing, and revenue cycle functions to support accurate genetic testing claims, reduce administrative rework, and help health plans make informed coverage decisions.

Science that serves people

We’re scientists, but we’re also parents, siblings, and caregivers who understand how powerful an answer can be.